Growth Business

JUNE 5, 2023

By Anna Jordan on Growth Business - Your gateway to entrepreneurial success Women founders who sell equity stakes have to give up a larger proportion of their shareholdings than male founders. per cent after raising equity compared to 29.1 per cent between 2021 and 2022, lower than the 9 per cent fall across the board. “We

Equities 100

Equities Initial Public Offering Business Investment 100

OfficeHours

AUGUST 20, 2023

Written by a Top OfficeHours Private Equity Coach Is PE a Good Fit for you? To know if the buyside is right for you, let’s start with a textbook understanding of “What is private equity?” During the hold period, the private equity firm can improve operations, management structure, and financial strategies to optimize the business.

Private Equity 130

Private Equity Equities Investment Banking Finance 130

The Harvard Law School Forum

OCTOBER 19, 2022

Posted by Ian Nussbaum, Bill Roegge, and Meredith Klionsky, Cooley LLP , on Wednesday, October 19, 2022 Editor's Note: Ian A. The rise of founder-led, venture capital-backed companies in recent years has coincided with a surge of companies implementing dual-class share structures in connection with their initial public offerings.

M&A 103

M&A IPO Shares Stock 103

Cooley M&A

JANUARY 25, 2023

Although 2022 saw a general decline in M&A activity in the life sciences industry compared to 2021’s frenetic pace (when deal volume was up 52% from 2020 ), life sciences deal flow in 2022 on balance remained strong despite the headwinds. Let’s dig in. Let’s dig in.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

MergersCorp M&A International

JULY 5, 2024

In 2023 the primary market for global convertibles was more than double since 2022, with volumes reaching USD 78Bn via 115 new issues. This shift is largely driven by the challenges these companies face in accessing traditional equity markets, particularly in the U.S.

Debt 52

Debt Stock Initial Public Offering Capital 52

Cooley M&A

JANUARY 30, 2024

Globally, 229 campaigns launched in 2023, just under 2022 campaign levels, ushering in the most active two-year period on record. [1] 1] Activism in Europe was a core driver of activity, representing 28% of all campaigns and a 30% increase from 2022. [2] 4] Activists won 134 board seats globally in 2023, a 30% increase from 2022.

Private Equity 52

Private Equity M&A Capital Investors 52

Cooley M&A

JANUARY 23, 2024

While the year saw an overall decline in M&A activity (down 17% from 2022) , total pharmaceuticals and life sciences deal value in 2023 increased by approximately 50% compared to 2022. Why did life sciences outperform the market? The last quarter of the year ended with a surge of deal activity. billion, Mirati for $5.8

M&A 52

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 52